Clinical Trials Browser

Phase 2 × Cephalexin × 90 days × Clear all

NCT05020574 2026-03-18

Microbiome and Association With Implant Infections

Phase 2 Recruiting

Breast Neoplasms, Genetic Predisposition to Disease